All Stories

  1. Akkermansia muciniphila, une bactérie pour lutter contre le syndrome métabolique
  2. Microbiote intestinal et obésité : impact des lipides bioactifs issus du système endocannabinoïde
  3. Inulin-type fructans modulate intestinal Bifidobacterium species populations and decrease fecal short-chain fatty acids in obese women
  4. Hypoxia Modulates the Differentiation Potential of Stem Cells of the Apical Papilla
  5. Glucose metabolism: Focus on gut microbiota, the endocannabinoid system and beyond
  6. When specific gut microbes reveal a possible link between hepatic steatosis and adipose tissue
  7. Saccharomyces boulardii Administration Changes Gut Microbiota and Reduces Hepatic Steatosis, Low-Grade Inflammation, and Fat Mass in Obese and Type 2 Diabetic db/db Mice
  8. Prebiotics supplementation improves the endothelial dysfunction in n-3 PUFA-depleted ApoE-/-mice
  9. Gut microbiota and GLP-1
  10. Positive interaction between prebiotics and thiazolidinedione treatment on adiposity in diet‐induced obese mice
  11. Prebiotics and Lipid Metabolism
  12. Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity
  13. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics
  14. CNS Regulation of Energy Balance
  15. Akkermansia muciniphila
  16. Hypothalamic Apelin/Reactive Oxygen Species Signaling Controls Hepatic Glucose Metabolism in the Onset of Diabetes
  17. Gut Microbial Metabolites of Polyunsaturated Fatty Acids Correlate with Specific Fecal Bacteria and Serum Markers of Metabolic Syndrome in Obese Women
  18. Role of the Lower and Upper Intestine in the Production and Absorption of Gut Microbiota-Derived PUFA Metabolites
  19. The gut microbiota manages host metabolism
  20. Gut microbiota, enteroendocrine functions and metabolism
  21. Impact of PPAR-α induction on glucose homoeostasis in alcohol-fed mice
  22. Probiotics, prebiotics, and the host microbiome: the science of translation
  23. Curcuma longa Extract Associated with White Pepper Lessens High Fat Diet-Induced Inflammation in Subcutaneous Adipose Tissue
  24. Microbial Modulation of Energy Availability in the Colon Regulates Intestinal Transit
  25. Gut microbiota and metabolic disorders
  26. Roux-en-Y gastric bypass surgery in rats alters gut microbiota profile along the intestine
  27. Targeted nanoparticles with novel non-peptidic ligands for oral delivery
  28. Toll-Like Receptor 4 Knockout Mice Are Protected against Endoplasmic Reticulum Stress Induced by a High-Fat Diet
  29. Gut microbiota and obesity: lessons from the microbiome
  30. Implication of fermentable carbohydrates targeting the gut microbiota on conjugated linoleic acid production in high-fat-fed mice
  31. Dietary supplementation with Agaricus blazei murill extract prevents diet‐induced obesity and insulin resistance in rats
  32. P1025 Modulation du microbiote intestinal par les traitements hypolipémiants : relation avec le métabolisme lipidique de l’hôte
  33. 056 Le système endocannabinoïde participe aux altérations métaboliques du tissu adipeux lors du développement de l’obésité
  34. Chronic Endocannabinoid System Stimulation Induces Muscle Macrophage and Lipid Accumulation in Type 2 Diabetic Mice Independently of Metabolic Endotoxaemia
  35. Diabetes, obesity and gut microbiota
  36. Gut microbiota and metabolic disorders: how prebiotic can work?
  37. Evaluation of the relationship between GPR43 and adiposity in human
  38. Prebiotic approach alleviates hepatic steatosis: Implication of fatty acid oxidative and cholesterol synthesis pathways
  39. Implication du microbiote intestinal dans l’obésité et les pathologies associées : quelles perspectives thérapeutiques et nutritionnelles ?
  40. Hedgehog Partial Agonism Drives Warburg-like Metabolism in Muscle and Brown Fat
  41. Mapping of oxygen by imaging lipids relaxation enhancement: A potential sensitive endogenous MRI contrast to map variations in tissue oxygenation
  42. Hypothalamic AgRP-neurons control peripheral substrate utilization and nutrient partitioning
  43. Endurance training in mice increases the unfolded protein response induced by a high-fat diet
  44. Role of intestinal permeability and inflammation in the biological and behavioral control of alcohol-dependent subjects
  45. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity
  46. The Loss of Metabolic Control on Alcohol Drinking in Heavy Drinking Alcohol-Dependent Subjects
  47. Crosstalk between the gut microbiota and the endocannabinoid system: impact on the gut barrier function and the adipose tissue
  48. Restoring Specific Lactobacilli Levels Decreases Inflammation and Muscle Atrophy Markers in an Acute Leukemia Mouse Model
  49. Polyphenol-rich extract of pomegranate peel alleviates tissue inflammation and hypercholesterolaemia in high-fat diet-induced obese mice: potential implication of the gut microbiota
  50. Dietary Supplementation With Agaricus Blazei Murill Extract Prevents Diet-Induced Obesity and Insulin Resistance in Rats
  51. Tetrahydro iso-Alpha Acids from Hops Improve Glucose Homeostasis and Reduce Body Weight Gain and Metabolic Endotoxemia in High-Fat Diet-Fed Mice
  52. O11 Le système endocannabinoïde contrôle le métabolisme du tissu adipeux, l’homéostasie glucidique et l’endotoxémie métabolique chez des souris obèses
  53. P193 Implication de l’apeline dans le controle des contractions intestinales chez la souris normale ou obese/diabétique
  54. PO9 «Akkermansia muciniphila» : Une nouvelle bactérie jouant un rôle clé dans la fonction barrière de l’intestin, l’inflammation et les désordres métaboliques associés à l’obésité ?
  55. P270 Effets anti-inflammatoires et hypolipémiants des polyphénols de grenade chez la souris obèse : implication potentielle du microbiote intestinal
  56. Ripened Dairy Products Differentially Affect Hepatic Lipid Content and Adipose Tissue Oxidative Stress Markers in Obese and Type 2 Diabetic Mice
  57. Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin–glucan fiber improves host metabolic alterations induced by high-fat diet in mice
  58. Lipides et inflammation postprandiale : impact du microbiote intestinal
  59. Interaction Between Obesity and the Gut Microbiota: Relevance in Nutrition
  60. Targeting gut microbiota in obesity: effects of prebiotics and probiotics
  61. Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARγ-related adipogenesis in the white adipose tissue of high-fat diet-fed mice
  62. Involvement of gut microbial fermentation in the metabolic alterations occurring in n-3 polyunsaturated fatty acids-depleted mice
  63. Prebiotic Effects of Wheat Arabinoxylan Related to the Increase in Bifidobacteria, Roseburia and Bacteroides/Prevotella in Diet-Induced Obese Mice
  64. Increasing endogenous 2‐arachidonoylglycerol levels counteracts colitis and related systemic inflammation
  65. The gut microbiome as therapeutic target
  66. Gut Microbiota and the Pathogenesis of Insulin Resistance
  67. Jejunum Inflammation in Obese and Diabetic Mice Impairs Enteric Glucose Detection and Modifies Nitric Oxide Release in the Hypothalamus
  68. Lipides et inflammation postprandiale : impact du microbiote intestinal
  69. Altered Gut Microbiota and Endocannabinoid System Tone in Obese and Diabetic Leptin-Resistant Mice: Impact on Apelin Regulation in Adipose Tissue
  70. Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome
  71. Initial Dietary and Microbiological Environments Deviate in Normal‐weight Compared to Overweight Children at 10 Years of Age
  72. Prebiotic effects: metabolic and health benefits
  73. The endocannabinoid system links gut microbiota to adipogenesis
  74. Nutritional modulation of gut microbiota in the context of obesity and insulin resistance: Potential interest of prebiotics
  75. Reply
  76. Drosophila Genome-wide Obesity Screen Reveals Hedgehog as a Determinant of Brown versus White Adipose Cell Fate
  77. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota
  78. Coenzyme Q10 supplementation lowers hepatic oxidative stress and inflammation associated with diet-induced obesity in mice
  79. Gut Microbiota, Diet, Endotoxemia, and Diseases
  80. An Adiponectin-Like Molecule with Antidiabetic Properties
  81. Critical role of Kupffer cells in the management of diet-induced diabetes and obesity
  82. Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis
  83. Dietary supplementation with chitosan derived from mushrooms changes adipocytokine profile in diet-induced obese mice, a phenomenon linked to its lipid-lowering action
  84. Modulation nutritionnelle du microbiote intestinal : impact sur la perméabilité intestinale et les désordres métaboliques
  85. The Role of the Gut Microbiota in Energy Metabolism and Metabolic Disease
  86. 715 EXOGENOUS STEATOSIS AND HEPATIC INSULIN RESISTANCE ARE EARLY CONSEQUENCES OF HIGH FAT FEEDING
  87. O19 Rôle de l’apeline cérébrale dans le maintien de l’homéostasie glucidique
  88. Modulation nutritionnelle de la flore intestinale : une nouvelle approche diététique dans la prise en charge de l’obésité ?
  89. Lipid peroxidation is not a prerequisite for the development of obesity and diabetes in high-fat-fed mice
  90. Gut microbiota and pregnancy, a matter of inner life
  91. Apelin Stimulates Glucose Utilization in Normal and Obese Insulin-Resistant Mice
  92. Immunomodulatory properties of two wheat bran fractions – aleurone-enriched and crude fractions – in obese mice fed a high fat diet
  93. Brain Glucagon-Like Peptide 1 Signaling Controls the Onset of High-Fat Diet-Induced Insulin Resistance and Reduces Energy Expenditure
  94. Les 10es Entretiens de nutrition, institut Pasteur de Lille L’obésité, une maladie nutritionnelle ?
  95. Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding
  96. Implication de la flore intestinale dans le métabolisme énergétique
  97. Physiological effects of dietary fructans extracted fromAgave tequilanaGto. andDasylirionspp.
  98. Prebiotics and Modulation of Gastrointestinal Peptides
  99. Endocrinology of the Gastrointestinal Tract and Modulation of Satiety
  100. Response to Comment on: Cani et al. (2007) Metabolic Endotoxemia Initiates Obesity and Insulin Resistance: Diabetes 56:1761–1772
  101. Gut microflora as a target for energy and metabolic homeostasis
  102. Targeted Deletion of AIF Decreases Mitochondrial Oxidative Phosphorylation and Protects from Obesity and Diabetes
  103. Lower Insulin Secretory Response to Glucose Induced by Artificial Nutrition in Children: Prolonged and Total Parenteral Nutrition
  104. GLUT2 and the incretin receptors are involved in glucose-induced incretin secretion
  105. Une flore intestinale saine pour un métabolisme énergétique sain
  106. Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats
  107. Comparison of glycemic index of spelt and wheat bread in human volunteers
  108. Non-digestible oligosaccharides
  109. Relation between colonic proglucagon expression and metabolic response to oligofructose in high fat diet-fed mice
  110. Improvement of Glucose Tolerance and Hepatic Insulin Sensitivity by Oligofructose Requires a Functional Glucagon-Like Peptide 1 Receptor
  111. GLP-1 et détection cérébrale du glucose, un relais de régulation de l’homéostasie glucidique
  112. Oligofructose promotes satiety in healthy human: a pilot study
  113. A place for dietary fibre in the management of the metabolic syndrome
  114. Oligofructose Promotes Satiety in Rats Fed a High‐Fat Diet: Involvement of Glucagon‐Like Peptide‐1
  115. Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats
  116. Impact of inulin and oligofructose on gastrointestinal peptides
  117. Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide
  118. Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats
  119. Phytosterol analysis and characterization in spelt (Triticum aestivum ssp. spelta L.) and wheat (T. aestivum L.) lipids by LC/APCI-MS
  120. Incretin Hormones